Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group.

Pigazzi M, Manara E, Bisio V, Aveic S, Masetti R, Menna G, Zecca M, Pession A, Locatelli F, Basso G.

Blood. 2012 Nov 1;120(18):3860-2. doi: 10.1182/blood-2012-09-454454. No abstract available.

2.

Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U.

J Clin Oncol. 2010 Jun 1;28(16):2682-9. doi: 10.1200/JCO.2009.25.6321. Epub 2010 May 3.

PMID:
20439630
3.
4.

Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance.

Hutchings Hoffmann M, Wirenfeldt Klausen T, Hasle H, Schmiegelow K, Brondum-Nielsen K, Johnsen HE.

Haematologica. 2005 Jul;90(7):984-6.

5.

Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia.

Kruizinga RC, de Jonge HJ, Kampen KR, Walenkamp AM, de Bont ES.

Pediatr Blood Cancer. 2011 Feb;56(2):294-7. doi: 10.1002/pbc.22783.

PMID:
20981743
6.

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE, van Galen JF, Beverloo HB, Sonneveld E, Kaspers GJ, Trka J, Baruchel A, Zimmermann M, Creutzig U, Reinhardt D, Pieters R, Valk PJ, Zwaan CM.

Blood. 2011 Sep 29;118(13):3645-56. doi: 10.1182/blood-2011-04-346643. Epub 2011 Aug 2.

8.

Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia.

Brown T, Swansbury J, Taj MM.

Leuk Lymphoma. 2012 Feb;53(2):338-41. doi: 10.3109/10428194.2011.614703. Epub 2011 Sep 23. No abstract available.

PMID:
21846182
9.

[Flt-3/ITD mutation in pediatric leukemia and its clinical significance].

Wang J, Wang T, Li S, Lin L, Gang Y.

Ai Zheng. 2007 Jan;26(1):58-63. Chinese.

PMID:
17222369
10.

Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.

Delaunay J, Vey N, Leblanc T, Fenaux P, Rigal-Huguet F, Witz F, Lamy T, Auvrignon A, Blaise D, Pigneux A, Mugneret F, Bastard C, Dastugue N, Van den Akker J, Fière D, Reiffers J, Castaigne S, Leverger G, Harousseau JL, Dombret H; French Acute Myeloid Leukemia Intergroup; Groupe Ouest-Est des Leucémies Aiguës Myéoblastiques; Leucémies Aiguës Myéoblastiques de l'Enfant; Acute Leukemia French Association; Bordeaux-Grenoble-Marseille-Toulouse cooperative groups.

Blood. 2003 Jul 15;102(2):462-9. Epub 2003 Mar 20. Review.

11.

Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia.

Bang SM, Ahn JY, Park J, Park SH, Park J, Cho EK, Shin DB, Lee JH, Yoo SJ, Jeon IS, Kim YK, Kim HJ, Kim HN, Lee IK, Kang HJ, Shin HY, Ahn HS.

J Korean Med Sci. 2008 Oct;23(5):833-7. doi: 10.3346/jkms.2008.23.5.833.

12.

Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia.

Jian P, Yan WS, Chao SL, Liang P, Zhen L, Ling QB, Hong LY, Ping LY, Jian W, Fang JM, Ling L, Dong WX, Ming ZX, Jian N.

J Pediatr Hematol Oncol. 2012 Jan;34(1):43-6. doi: 10.1097/MPH.0b013e3182277276.

PMID:
22052167
13.

Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients.

Zhang Y, Wei H, Wang M, Huai L, Mi Y, Zhang Y, Lin D, Liu B, Li W, Zhou C, Rao Q, Wang J.

Leuk Res. 2011 Oct;35(10):1301-6. doi: 10.1016/j.leukres.2011.01.019. Epub 2011 Feb 12.

PMID:
21316759
14.

High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.

Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F; Italian Pediatric Group for Bone Marrow Transplantation.

Bone Marrow Transplant. 2001 Jul;28(2):131-6.

15.

Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.

Lugthart S, Gröschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL, Jan Ossenkoppele G, Vellenga E, van den Berg-de Ruiter E, Schanz U, Verhoef G, Vandenberghe P, Ferrant A, Köhne CH, Pfreundschuh M, Horst HA, Koller E, von Lilienfeld-Toal M, Bentz M, Ganser A, Schlegelberger B, Jotterand M, Krauter J, Pabst T, Theobald M, Schlenk RF, Delwel R, Döhner K, Löwenberg B, Döhner H.

J Clin Oncol. 2010 Aug 20;28(24):3890-8. doi: 10.1200/JCO.2010.29.2771. Epub 2010 Jul 26.

PMID:
20660833
16.

AML1/RUNX1 gene point mutations in childhood myeloid malignancies.

Migas A, Savva N, Mishkova O, Aleinikova OV.

Pediatr Blood Cancer. 2011 Oct;57(4):583-7. doi: 10.1002/pbc.22980. Epub 2011 Feb 3.

PMID:
21294243
17.

Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group.

Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N, Barnard DR, Wells RJ, Buckley JD, Lange BJ, Woods WG.

J Pediatr Hematol Oncol. 2003 Oct;25(10):760-8.

PMID:
14528097
18.

Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.

Marques EA, Neves L, Fonseca TC, Lins MM, Pedrosa F, Lucena-Silva N.

J Pediatr Hematol Oncol. 2011 Aug;33(6):470-4. doi: 10.1097/MPH.0b013e3181fb8f61.

PMID:
21436736
19.

[Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].

Zou Y, Wang H, Chen XJ, Wang SC, Zhang L, Chen YM, Zhu XF.

Zhonghua Xue Ye Xue Za Zhi. 2006 Sep;27(9):621-5. Chinese.

PMID:
17278430
20.

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO.

Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.

Supplemental Content

Support Center